1. Background {#sec1}
=============

Tuberculosis (TB) remains one of the most important causes of pediatric mortality worldwide, especially in areas with high HIV prevalence. There are approximately nine million new TB cases each year, with ten percent of those occurring in children, equaling almost one million new pediatric cases each year. Seventy-five percent of those are in twenty-two high-burden countries, which also tend to have fewer resources for diagnosis. Accurate and timely diagnosis of pediatric TB remains crucial because children are more likely than adults to progress from latent infection to active TB disease \[[@B1]\].

One of the largest challenges in preventing morbidity and mortality from TB among the pediatric population is the difficulty in making a timely diagnosis. Diagnostic approaches relying on symptoms, chest radiographs, tuberculin skin tests, or cultures all have particular challenges within the pediatric population. TB symptoms vary and overlap with other common pediatric diseases, especially in children who are coinfected with TB and HIV. Cough, anorexia, and weight loss are common in TB but nonspecific and might lead to overdiagnosis if used alone \[[@B2]\].

Chest radiography also is difficult to interpret in pediatric patients, who are less likely to have cavitations or clear radiological signs of TB. Mediastinal lymphadenopathy is often regarded as a radiologic hallmark of primary TB; however, this is difficult to diagnose on a plain chest X-ray (CXR), which may be of variable quality, particularly in some resource-limited settings. Also, significant interobserver variation exists when interpreting pediatric CXR for TB diagnosis \[[@B3]\].

Previous studies have shown various utility in using the tuberculin skin test (TST) in a highly BCG vaccinated population due to a concern for a high rate of false positives \[[@B4]\]. Though some evidence has shown that BCG-vaccinated children with known exposure to TB have a higher rate of positive tests than community controls \[[@B5]\], this study did not address the utility in other populations where TST may not be as sensitive, such as HIV-infected or malnourished children.

Pediatric TB tends to be pauci-bacillary and thus it is also more difficult to diagnose using cultures, especially in children who are too young to provide sputum \[[@B1]\]. Attempts have been made to improve the utility of culture-proven diagnosis by using induced sputum samples or gastric aspirates. These samples can still be difficult to obtain in children. Moreover, conducting these procedures in resource-limited settings can be difficult \[[@B6]\]. Because of the challenges in diagnosing pediatric TB through individual clinical signs and symptoms, radiological studies, or laboratory examinations, point-based scoring systems or diagnostic criteria are often used to assist in the diagnosis of TB in children.

The first major point-based scoring system was introduced by Stegen et al. in Chile in 1969 \[[@B7]\] and has continued to be modified and used around the world through the present \[[@B8]--[@B14]\]. The Keith Edwards criteria were originally published in 1987 \[[@B15]\] and also have been widely used \[[@B16]--[@B19]\] outside the original location of Papua New Guinea. Of the many diagnostic systems developed, the World Health Organization (WHO) criteria, originally published in 1983, are the most widely used \[[@B20]\]. The major objective of all of the diagnostic systems is to provide a consistent and accurate way to diagnose pediatric TB, especially in resource-limited settings.

Although these scoring systems and diagnostic criteria are commonly used \[[@B21]\], their reliability and validity remain unclear. Different diagnostic criteria are used in different settings, and they may or may not have been validated for those locations. Moreover, the challenges of using these criteria in settings where many of the children are malnourished or coinfected with HIV have not been fully examined. Many of the diagnostic systems were developed prior to the onset of the HIV epidemic and may not perform adequately in children with coinfection. Since TB is a leading cause of mortality among the world\'s 2.3 million HIV-infected children, diagnosing TB among coinfected children is a particularly important challenge and may require significant adaptations of current diagnostic systems \[[@B22]\].

Prevention of childhood morbidity and mortality due to TB requires accurate and timely diagnosis. A previous systematic review of pediatric TB diagnostic strategies, published in 2002, recommended standardization of definitions and characteristics, pointing out the need for new diagnostic approaches \[[@B21]\]. Since that review, at least twenty-one new papers on pediatric TB diagnosis have been published, including several highlighting new strategies such as the Brazil Ministry of Health system \[[@B23]--[@B25]\] and the Marais criteria \[[@B26]\]. In addition, the population of children living with HIV infection has reached 2.3 million, simultaneously expanding the numbers of children vulnerable to TB disease \[[@B22]\]. This systematic review seeks to systematically identify, review, and compare various methods of diagnosis of TB in children in order to inform clinical practice and future research in this area. It aims to organize the scoring systems and diagnostic criteria based on their common components, critically analyze the extent to which the criteria are validated, and highlight those that have focused specifically on children that are coinfected with HIV and TB.

2. Methods {#sec2}
==========

We searched several bibliographic databases, including MEDLINE (through October 19, 2009), EMBASE, and relevant websites such as those for the World Health Organization. We used the following strategy: (tuberculosis/diagnosis) \[MeSH heading\] AND (criteria\* OR screen\* OR guideline\* OR scor\*). Three authors (S. O. Ayaya, J. F. Woodward, and E. C. Pearce) reviewed all returned titles and excluded articles that obviously did not involve children or tuberculosis. These authors then reviewed abstracts of remaining articles to determine which studies examined scoring systems or diagnostic criteria used in the diagnosis of pediatric tuberculosis. The bibliographies of all relevant articles were also reviewed for potential articles.

Two investigators (J. F. Woodward and E. C. Pearce) independently reviewed the remaining articles, independently deciding on inclusion in the review using a standard form with predetermined eligibility criteria. Disagreements were resolved by consensus. For inclusion, the articles needed to describe a descriptive or interventional study involving the use of a clinical diagnostic system to diagnose tuberculosis in pediatric patients. Only English language articles were included. Pediatric patients were described as individuals less than 18 years of age. Clinical diagnostic systems included both scoring systems and diagnostic criteria. Scoring systems were defined as point-based criteria with set numerical cutoffs for a positive diagnosis. Diagnostic criteria were defined as nonpoint-based systems in which a certain number of criteria out of the total or out of each group were needed for diagnosis. Studies analyzing the diagnosis of pediatric tuberculosis in general without using or evaluating a particular scoring system or diagnostic criteria were used as background information only for the review. Each article was analyzed to determine the study setting, study design and methods, sample characteristics, type of diagnostic system used, reference or gold standard used for comparison, and efforts at validation of the diagnostic system. We excluded duplicate publications of the same findings.

3. Results {#sec3}
==========

The systematic literature search identified 2261 articles. The online search of MEDLINE yielded 2011 articles, and the search of EMBASE yielded 250 articles, many of which were also found by the MEDLINE search. Additional potential studies were identified through searches of bibliographies. After articles that did not address the diagnosis of tuberculosis in children were excluded, 408 articles remained. Further articles were excluded upon closer review because they did not include pediatric patients, did not include a scoring system or diagnostic criteria, or focused only on screening for latent tuberculosis. Articles that briefly mentioned a scoring system but did not give details or include how it was used in the study were also excluded. Forty articles met the general study criteria.

3.1. Clinical Diagnostic Systems Used for TB Diagnosis {#sec3.1}
------------------------------------------------------

From the forty articles that included a clinical diagnostic system, we extracted information on the setting, location, sample size, type of system/criteria used, efforts at validation, choice of gold standard, and the effect of HIV coinfection in the population. The characteristics of these studies, including the validation strategies, are summarized in Tables [1](#tab1){ref-type="table"}, [2](#tab2){ref-type="table"}, and [3](#tab3){ref-type="table"}. Eighteen studies used scoring systems; these studies could be further divided into five groups based on a common initial system modified by different authors ([Table 1](#tab1){ref-type="table"}). The three major groups were the following: (1) the Kenneth Jones/Stegen-Toledo system \[[@B7]--[@B14]\]; (2) the Keith Edwards system \[[@B15]--[@B19]\]; (3) the Brazil Ministry of Health (MOH) system \[[@B23]--[@B25]\]. Fourie et al. \[[@B27]\] and Bergman \[[@B28]\] also presented new systems without further published studies. Eighteen studies used diagnostic criteria. These studies could be further divided into five groups of diagnostic criteria presented by Ghidey and Habte \[[@B29]\], Migliori et al. \[[@B30]\], Mahdi et al. \[[@B31]\], Salazar et al. \[[@B32]\], Marais et al. \[[@B26]\], the WHO guidelines \[[@B33]--[@B42]\], Osborne \[[@B43]\], Jeena et al. \[[@B44]\], and Ramachandran \[[@B45]\] ([Table 2](#tab2){ref-type="table"}). Four articles compared two or more scoring criteria \[[@B46]--[@B49]\] ([Table 3](#tab3){ref-type="table"}).

3.2. Validation of Clinical Diagnostic Systems for Pediatric TB Diagnosis {#sec3.2}
-------------------------------------------------------------------------

Of the above forty articles, sixteen attempted to validate the diagnostic system or systems ([Table 4](#tab4){ref-type="table"}). Gold standards used in validation varied greatly and ranged from positive cultures to clinical diagnosis to previous scoring criteria. The only study using cultures as the primary gold standard was Sant\'Anna et al. \[[@B24]\], which found a sensitivity of 89% and specificity of 86% when evaluating Brazil Ministry of Health criteria against a standard of culture-positive patients. Sant\'Anna et al. \[[@B25]\] also performed a retrospective analysis on a different study population using clinical consensus as the gold standard against which to compare the diagnostic criteria, resulting in similar sensitivity.

Culture for *Mycobacterium tuberculosis*is less sensitive in pediatric patients and difficult to obtain in resource-limited settings; therefore, the most common gold standard used to validate diagnostic systems was clinical diagnosis. The definition of clinical diagnosis varied widely between studies and was often not defined in detail. Because many of the studies were retrospective, clinical diagnosis was often simply defined as children who had been admitted with a diagnosis of TB \[[@B8], [@B34]\], with some studies also specifying that the children must have improved on anti-TB medication \[[@B13], [@B40], [@B41]\]. In one article, the study population was drawn from forty-four different hospitals, all of which used their own methods of clinical diagnosis \[[@B17]\]. However, in other studies, the method of clinical diagnosis was explained in depth. For example, van Rheenen described a detailed algorithm that included clinical findings, culture, CXR, TST, contact history, and response to treatment \[[@B18]\].

Previously described scoring criteria were also used as a gold standard; a few of the studies compared their modifications of a certain diagnostic system to the original. For example, Migliori et al. modify the criteria published by Ghidey and Habte \[[@B29]\] by focusing the criteria on pulmonary TB and adding response to treatment and use the original criteria as the gold standard in their analysis \[[@B30]\]. Salazar et al. then modified the Migliori criteria to develop the Peru criteria, and used the original Migliori criteria as the gold standard for comparison \[[@B32]\]. These are not traditional validation strategies as they assume the previous criteria have been validated to an extent that they may now be considered a gold standard in themselves.

Four published papers evaluated and compared multiple scoring systems and diagnostic criteria ([Table 3](#tab3){ref-type="table"}). In a 2002 systematic review, Hesseling et al. stressed the need for standardization of definitions and point values between the various algorithms \[[@B21]\]. As an update on Hesseling\'s review, this current review includes twenty-one new studies, including those evaluating the Brazil MOH scoring system \[[@B23]--[@B25]\] and the Marais criteria \[[@B26]\]. In 2008, Ahmed et al. published a review of TB diagnosis as well as treatment, focusing mainly on the Kenneth Jones and Keith Edwards systems \[[@B48]\] and suggesting the need for further research. Most recently, in 2009, Raquib et al. compared a newer diagnostic test (ALS assay) to clinical diagnosis, the Kenneth Jones, and the Keith Edwards scoring criteria \[[@B49]\], finding that sensitivity, specificity, and overall concordance was higher when the ALS assay was compared to clinical diagnosis than to the scoring criteria.

In a 2007 article, Edwards et al. used data from a retrospective review of TB cases at a pediatric hospital with a highprevalence of HIV infection to calculate scores for eight diagnostic scoring systems \[[@B47]\]. The decision to initiate treatment for TB was dependent on the scoring system used, with at least one scoring system recommending not to treat for 14% of the children studied. Except for the systems derived from a common original diagnostic system, correlation was poor to moderate for agreement of when to initiate treatment based on the various scoring systems.

3.3. Variation among Criteria {#sec3.3}
-----------------------------

Although all of the scoring criteria have aspects in common, their purposes and specifics have varied over the past 40 years since Stegen et al. published the original Kenneth Jones criteria. The Kenneth Jones criteria include laboratory tests but exclude clinical criteria such as cough and fever due to concerns that they would lower the specificity \[[@B7]\]. In contrast, the purpose of the Keith Edwards criteria was focused towards a completely clinical diagnosis, and thus excluded laboratory data except for a TST \[[@B15]\].

Both the Kenneth Jones and Keith Edwards criteria were designed for the diagnosis of both pulmonary and extrapulmonary tuberculosis. Because the clinical signs and symptoms of extrapulmonary tuberculosis may differ from those of pulmonary tuberculosis, several studies evaluated the ability of diagnostic strategies to identify pulmonary TB specifically ([Table 5](#tab5){ref-type="table"}). For example, the Brazil MOH system, designed specifically for pulmonary tuberculosis \[[@B24], [@B25]\], has shown a sensitivity of 89% and a specificity of 86%. The Migliori \[[@B30]\] and Marais \[[@B26]\] diagnostic criteria, also focused on pulmonary tuberculosis, demonstrated a sensitivity of 92% \[[@B31]\] and 82%, respectively. While the Migliori criteria have not been tested in children with coinfection, the sensitivity of the Marais criteria decreased to 51--56% when children under three years of age and HIV infected children were included \[[@B26]\].

A salient difference between the various clinical diagnostic approaches was the choice of included criteria. The criteria included most commonly were the tuberculin skin test (TST) and positive history of TB contact; however, the definition of these criteria was not standardized. For example, the definition of a positive TST varies widely among studies \[[@B7], [@B15]\]. A positive history of TB contact also was defined in various ways, such as requiring confirmed sputum-positive contact \[[@B37]\] or only a self-report of contact \[[@B30]\]. In some cases, the history of contact had to be within the past two years \[[@B14]\]. Using both the TST and the positive contact history may also be redundant if both are included. Variability is also seen in the other criteria, such as clinical symptoms and CXR. The various definitions and subjectivity of many of the criteria included in the diagnostic approaches make it difficult to compare the diagnostic strategies and the attempts at validation. In addition, clinicians likely vary in how they implement the scoring criteria, thus, making the diagnostic thresholds even less consistent.

3.4. Clinical Diagnostic Systems in HIV-Infected Patients {#sec3.4}
---------------------------------------------------------

A few studies specifically examined TB diagnosis in HIV-infected children ([Table 6](#tab6){ref-type="table"}). In his comparison of eight diagnostic scoring systems, Edwards showed that HIV-infected children tended to have higher scores, especially when the Keith Edwards system was used, leading to a concern for over-diagnosis of TB in HIV-infected children \[[@B47]\]. Marais et al. found that the Marais diagnostic criteria were less sensitive (56% compared to 82%) and less specific (62% compared to 90%) when evaluating children with HIV as opposed to children without HIV. The positive predictive value also decreased to 62% in HIV-infected children as compared to 82% in children without HIV \[[@B26]\]. Viani et al. looked at a small cohort of coinfected children in Mexico retrospectively and found that 77% had scores indicating highly probable TB when using the Stegen-Toledo criteria \[[@B8]\]. Finally, in a 2009 analysis of the Brazil MOH criteria, Pedrozo et al. found that while coinfected children did score slightly lower than HIV-uninfected children, their scores were still significantly higher than children without TB \[[@B25]\].

4. Discussion {#sec4}
=============

We identified and reviewed forty different studies of twenty-two unique scoring systems or diagnostic criteria that were developed from five original scoring systems and five original diagnostic criteria. These diagnostic approaches varied in the types of clinical signs and symptoms included in the criteria, the inclusion or exclusion of laboratory testing, and even their diagnostic focus (i.e., pulmonary TB alone or pulmonary and extrapulmonary TB). Studies designed to validate the various diagnostic systems varied significantly in the gold standard chosen for comparison. Because the publication dates of the articles range over the last fifty years, some criteria were developed and evaluated prior to the HIV epidemic, while other studies focused specifically on coinfected children.

The gold standards chosen to evaluate the validity of these diagnostic strategies also varied widely. Cultures can be difficult to obtain in children. Because tuberculous disease in children is often pauci-bacillary, the diagnostic yield of cultures in children is often poor. Although one study used culture as the gold standard \[[@B25]\], others used positive response to treatment \[[@B13]\], CXR \[[@B35]\], or a previous scoring criteria \[[@B30]\]. The most common gold standard was clinical diagnosis. Interestingly, in a study of the ALS assay for diagnosing active TB disease, the assay actually correlated better with clinical diagnosis than either the Kenneth Jones or Keith Edwards scoring criteria \[[@B49]\]. Unfortunately, clinical diagnosis is likely to depend strongly upon the experience and knowledge base of the clinician and thus may be less reliable in settings where clinicians have less training. To allow for comparison of criteria across different studies and settings, future studies need to employ a more consistent gold standard. Ideally, this would be culture-based, as this is a standard for validation that could be reliably replicated across settings. However, because cultures are difficult to obtain in resource-limited settings and can lead to a delay in treatment, performing studies with culture as the gold standard can be difficult.

In addition to using a variety of gold standards, the various studies often included very different sample populations. Some studies did not clearly describe the characteristics of the patient population or how they were selected. Many were retrospective, often utilizing chart review. Ideally, prospective studies of diagnostic systems would evaluate a clearly defined sample of participants with a spectrum of disease that is representative of the patients to which the criteria would be applied in clinical practice. It is essential that researchers clearly describe the sample selection process and inclusion criteria in such studies to allow for more accurate comparisons of criteria across different populations or settings and to promote the utility of these systems in clinical practice.

Another challenge in prospective studies of TB diagnosis is the bias that is introduced when, as found in some of these studies, the inclusion or screening criteria for participants often include similar clinical features as the diagnostics systems being evaluated. For example, Pedrozo et al. used history of contact, CXR, and TST result as part of the criteria for inclusion in the study. Chest X-ray and TST were also used as part of their diagnostic gold standard to differentiate latent TB from no TB from active TB disease. All three inclusion criteria are also used in the Brazil MOH scoring system being evaluated in this study \[[@B25]\]. This makes it difficult to interpret the accuracy of a diagnostic system and its ability to predict a diagnosis of TB in a particular patient or patient population. This overlap also causes difficulty in determining the relative importance of particular signs or symptoms within the diagnostic system.

The largest shift in the newer diagnostic systems as compared to Kenneth Jones and Keith Edwards is the focus on pulmonary tuberculosis alone. Diagnostic systems focusing simply on pulmonary TB, such as the Brazil MOH and Marais criteria, have demonstrated higher sensitivities and specificities than those developed to diagnose both extrapulmonary and pulmonary TB. Because children have a higher incidence of extrapulmonary TB \[[@B51]\], using diagnostic systems targeted at pulmonary TB only addresses part of the diagnostic challenge. On the other hand, because TB presents with varied signs and symptoms depending on the site of disease, it is difficult to conceive of a single diagnostic system that could diagnose with high sensitivity and specificity the various types of tuberculosis infections (e.g., vertebral, abdominal, and pulmonary TB). Furthermore, many children with extrapulmonary TB also have pulmonary disease \[[@B52]\]. A new system of classification, focusing on the severity of the disease rather than location, has recently been published and may also be a more reliable and reproducible method. If this is well validated in different settings, it may allow various diagnostic systems to be better compared than is currently possible \[[@B53]\].

At this time, the Brazil MOH scoring system has the most studies evaluating its validity with consistently high sensitivities and specificities. In each of the three studies of this criteria, the scoring system was tested against a slightly different gold standard, ranging from clinical criteria \[[@B23], [@B25]\] to culture-proven disease \[[@B24]\]. Although this may make some comparisons difficult with the lack of a standard gold standard, the fact that the scoring system holds up fairly well when tested in different ways actually strengthens the evidence for its validity. Though it has not been tested outside of Brazil, it has been tested in both an inpatient \[[@B24]\] and outpatient setting \[[@B23], [@B25]\]. The performance of the scoring system has also been evaluated in HIV-infected patients. These coinfected children still scored significantly above the cutoff for a diagnosis of TB \[[@B23]\]. All of these evaluations point favorably toward the validity of this scoring system. Evaluating the Brazil MOH scoring system in additional settings worldwide should be an important next step.

The findings of this systematic review are limited by the design and quality of the studies included. The lack of consistent and sometimes clearly defined inclusion criteria among the studies makes it difficult to compare sensitivity and specificity across the different diagnostic systems. Most of the various diagnostic systems have only been evaluated in specific geographic locations or single populations; few studies evaluate a particular diagnostic system in multiple geographic regions or patient populations. Fewer studies have compared the diagnostic yield of multiple criteria in the same patient population. Finally, the increase in the prevalence of HIV during the publication range of these studies makes it difficult to compare studies from thirty years ago to those more recently published. Although this paper includes more than twenty new studies since Hesseling et al. was published in 2002 \[[@B21]\], the number of articles assessing the validity of each diagnostic system is still relatively small. The paper also did not include unpublished data or non-English publications.

5. Conclusion {#sec5}
=============

Clinical diagnostic systems in use for many years (e.g., the original Kenneth Jones criteria) and those more recently developed (e.g., the Brazil MOH criteria) have generally been developed, and subsequently adapted, in an attempt to accurately and reliably diagnose tuberculosis in children. As more continues to be learned about the disease and newer, more accurate tests are developed, methods of diagnosis will likely be altered further. It remains crucial that these methods remain applicable to resource-limited settings where the majority of children with TB are still most likely to be found. Although the studies included in this paper are heterogeneous and difficult to compare, the Brazil MOH criteria seems to emerge as the best validated in children with TB alone as well as those coinfected with TB and HIV. Due to the difficulty with obtaining cultures and the expense of the newer diagnostic tests, clinical scoring systems and diagnostic criteria will likely continue to be necessary in resource-limited settings for some time. However, unless additional studies identify refined diagnostic systems with improved sensitivity and specificity, they will likely mainly be utilized as initial screening tools or adjuncts to support clinical diagnosis. Improving the accuracy of diagnosis of pediatric TB is needed to ensure appropriate and timely treatment of those with active disease and to prevent unnecessary morbidity and mortality. Validated clinical diagnostic systems that can be implemented in resource limited settings can improve the accuracy and timeliness of tuberculosis in children; however, additional well-designed studies are needed to validate the accuracy and reliability of current scoring systems and diagnostic criteria.

###### 

Point-based scoring systems and studies evaluating these systems.

  Author                         Year   Country            Scoring criteria                           Changes                                                                                Study type
  ------------------------------ ------ ------------------ ------------------------------------------ -------------------------------------------------------------------------------------- -------------------------------------
  Stegen et al. \[[@B7]\]        1969   Chile              Kenneth Jones                              New                                                                                    Review with case reports
  Mathur et al. \[[@B9]\]        1974   India              Kenneth Jones                              Added marasmus to original criteria                                                    Prospective observational
  Nair and Philip \[[@B10]\]     1981   India              Kenneth Jones                              Changed point values, took away negative points for BCG, added response to treatment   Prospective
  Seth \[[@B11]\]                1991   India              Kenneth Jones                              Used Nair\'s adaptation                                                                Book excerpt
  Shah et al. \[[@B12]\]         1992   India              Kenneth Jones                              Added history of measles/whooping cough                                                Prospective observational
  Mehnaz and Arif \[[@B13]\]     2005   Pakistan           Kenneth Jones                              Modified multiple criteria, added and subtracted criteria                              Retrospective case control
  Oberhelmen et al. \[[@B14]\]   2006   Peru               Stegen-Toledo                              No modifications                                                                       Prospective observational
  Viani et al. \[[@B8]\]         2008   Mexico             Stegen-Toledo                              Added points for positive stain                                                        Retrospective chart review
                                                                                                                                                                                             
  Edwards \[[@B15]\]             1987   Papau New Guinea   Keith Edwards                              Original                                                                               Review article
  van Beekhuizen \[[@B16]\]      1998   Papua New Guinea   Keith Edwards                              No modifications                                                                       Prospective observational
  Weismuller et al. \[[@B17]\]   2002   Malawi             WHO score chart (modified Keith Edwards)   Added no response to malaria treatment, modified language                              Cross-sectional observational study
  van Rheenen \[[@B18]\]         2002   Zambia             Keith Edwards                              Modified language                                                                      Prospective cohort
  Narayan et al. \[[@B19]\]      2003   India              Keith Edwards                              Added no response to malaria treatment                                                 Prospective observational
                                                                                                                                                                                             
  Sant\'Anna et al. \[[@B24]\]   2006   Brazil             Brazil Ministry of Health                  New                                                                                    Retrospective case control
  Sant\'Anna et al. \[[@B25]\]   2004   Brazil             Brazil Ministry of Health                  No modifications                                                                       Retrospective
  Pedrozo et al. \[[@B23]\]      2009   Brazil             Brazil Ministry of Health                  No modifications                                                                       Prospective observational
                                                                                                                                                                                             
  Fourie et al. \[[@B27]\]       1998   Multiple           New                                        Set up new scoring criteria by consensus decision                                      Retrospective
                                                                                                                                                                                             
  Bergman \[[@B28]\]             1995   Zimbabwe           New                                        New                                                                                    Review

###### 

Diagnostic classifications and studies evaluating these classifications.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                        Year   Country        Scoring criteria                           Changes                                                                                Study type
  ----------------------------- ------ -------------- ------------------------------------------ -------------------------------------------------------------------------------------- -------------------------------
  Ghidey and Habte \[[@B29]\]   1983   Ethiopia       New                                        New                                                                                    Prospective

  Migliori et al. \[[@B30]\]    1992   Uganda         Migliori---revised from Ghidey and Habte   Focused towards PTB, added response to treatment as a criteria                         Prospective

  Madhi et al. \[[@B31]\]       1999   South Africa   Migliori                                   No change                                                                              Prospective

  Salazar et al. \[[@B32]\]     2001   Peru           Migliori                                   Removed response to treatment. Created Peru criteria.                                  Prospective cohort

                                                                                                                                                                                        

  Marais et al. \[[@B26]\]      2006   South Africa   New                                        Symptom based approach                                                                 Prospective

                                                                                                                                                                                        

  World Health\                 1983   Multiple       New                                        New                                                                                    New guidelines
  Organization \[[@B20]\]                                                                                                                                                               

  Cundall \[[@B33]\]            1986   Kenya          1983 WHO guidelines                        Modifies by adding family contact                                                      Prospective

  Stoltz et al. \[[@B34]\]      1990   South Africa   Modified 1983 WHO guidelines               No change                                                                              Prospective

  Beyers et al. \[[@B35]\]      1994   South Africa   1983 WHO guidelines                        No change                                                                              Prospective

  Gie et al. \[[@B36]\]         1995   South Africa   Modified 1983 WHO guidelines               No change                                                                              Prospective

  Schaaf et al. \[[@B37]\]      1995   South Africa   1983 WHO guidelines                        No change                                                                              Prospective

  Houwert et al. \[[@B38]\]     1998   South Africa   1994 WHO guidelines                        No change                                                                              Prospective

  Kiwanuka et al. \[[@B42]\]    2001   Malawi         1983 WHO guidelines                        Modified by using only certain radiological findings or positive TST for probable TB   Prospective

  Palme et al. \[[@B39]\]       2002   Ethiopia       Modified 1983 WHO guidelines               Required 2/6 criteria                                                                  Prospective case-control

  Theart et al. \[[@B40]\]      2005   South Africa   Modified 1983 WHO guidelines               No change                                                                              Retrospective

  Cohen et al. \[[@B41]\]       2008   UK             2006 WHO classification                    No change                                                                              Retrospective

                                                                                                                                                                                        

  Osborne \[[@B43]\]            1995   Zambia         Lusaka\'s UTH Criteria                     New                                                                                    Review article

  Jeena et al. \[[@B44]\]       1996   South Africa   Lusaka\'s UTH criteria                     No change                                                                              Prospective

                                                                                                                                                                                        

  Ramachandran \[[@B45]\]       1968   India          New                                        New                                                                                    Prospective and retrospective
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Studies evaluating and comparing multiple diagnostic systems.

  Author                        Year   Country        Findings
  ----------------------------- ------ -------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Hesseling et al. \[[@B21]\]   2002   South Africa   Analyzed 16 diagnostic systems, specifically looks at how systems have been adapted for HIV-infected and malnourished patients.
  Edwards et al. \[[@B47]\]     2007   Congo          Analyzed 8 scoring systems, found correlation to be poor to moderate. Decision to initiate treatment for TB was dependent on scoring system used in 14% of children. Selection had a greater impact in HIV-infected patients.
  Ahmed et al. \[[@B48]\]       2008   Bangladesh     Reviews previous scoring systems as well as Hesseling et al. \[[@B21]\] and Edwards et al. \[[@B47]\]
  Raqib et al. \[[@B49]\]       2009   Bangladesh     Analyzed a new diagnostic test (ALS assay) detecting antibodies secreted from circulating MTB-specific plasma cells in comparison to the Kenneth Jones and WHO/Keith Edwards scoring criteria as well as clinical diagnosis.

###### 

Studies attempting validation of diagnostic systems.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                         Year   Country        Scoring criteria                           Validation                                                                                                                       Gold standard
  ------------------------------ ------ -------------- ------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------
  Point-based scoring systems                                                                                                                                                                                                      

                                                                                                                                                                                                                                   

  Mathur et al. \[[@B9]\]        1974   India          Kenneth Jones                              Sens 73% (original criteria)\                                                                                                    Clinical diagnosis
                                                                                                  Sens 95% (modified criteria)                                                                                                     

  Shah et al. \[[@B12]\]         1992   India          Kenneth Jones                              Compared modified criteria to previous Kenneth Jones                                                                             Previous KJ

  Mehnaz and Arif\               2005   Pakistan       Kenneth Jones                              Retrospective analysis                                                                                                           Clinical control and response to treatment
  \[[@B13]\]                                                                                                                                                                                                                       

  Viani et al. \[[@B8]\]         2008   Mexico         Stegen-Toledo                              Retrospective analysis                                                                                                           Clinical diagnosis

                                                                                                                                                                                                                                   

  van Beekhuizen \[[@B16]\]      1998   Papua New\     Keith Edwards                              Sens 62%, spec 95%                                                                                                               Improvement on anti-TB treatment or positive CXR
                                        Guinea                                                                                                                                                                                     

  Weismuller et al.\             2002   Malawi         WHO score chart (modified Keith Edwards)   Sens 61% for all types of TB; 54% for PTB and 73% for EPTB                                                                       Clinical diagnosis---differed by various hospitals
  \[[@B17]\]                                                                                                                                                                                                                       

  van Rheenen \[[@B18]\]         2002   Zambia         Keith Edwards                              Sens 88%, spec 25%, PPV 55%, NPV 67%                                                                                             Diagnostic algorithm

  Narayan et al. \[[@B19]\]      2003   India          Keith Edwards                              Sens 91%, spec 88%                                                                                                               Clinical diagnosis

                                                                                                                                                                                                                                   

  Sant\'Anna et al. \[[@B24]\]   2006   Brazil         Brazil Ministry of Health                  Sens 89%, spec 86%                                                                                                               Culture positive and respiratory symptoms and/or CXR improved using exclusively anti-TB drugs

  Sant\'Anna et al. \[[@B25]\]   2004   Brazil         Brazil Ministry of Health                  82% very likely, 16% possible, 2.4% unlikely                                                                                     Clinical criteria and response to treatment

  Pedrozo et al. \[[@B23]\]      2009   Brazil         Brazil Ministry of Health                  Median score of TB positive groups higher than negative                                                                          Clinical criteria

                                                                                                                                                                                                                                   

  Fourie et al. \[[@B27]\]       1998   Multiple       New                                        Analyzed by age and country group: sens 30--73%, spec 10--75%, PPV 50--82%                                                       Positive radiologic or bacteriological data

                                                                                                                                                                                                                                   

  Diagnostic classification                                                                                                                                                                                                        

                                                                                                                                                                                                                                   

  Migliori et al. \[[@B30]\]     1992   Uganda         Migliori                                   Gastric aspirate: sens 96.8%, spec 92.2%, PPV 68.2%, NPV 99.4%. Response to treatment: sens 62.5%, 94.1%, PPV 57.7%, NPV 95.1%   Original Ghidey and Habte criteria

  Salazar et al. \[[@B32]\]      2001   Peru           Migliori                                   Sens 92% (Migliori) versus 80% (Peru). 3/3 Peru criteria had 73% PPV                                                             Migliori criteria (without RTT)

                                                                                                                                                                                                                                   

  Marais et al. \[[@B26]\]       2006   South Africa   New                                        Children ≥3 and HIV uninfected: sens 82.3%, spec 90.2%, PPV 82.3%.\                                                              Clinical criteria
                                                                                                  Children \<3 and HIV uninfected: sens 51.8%, spec 92.5%, PPV 90.1%.\                                                             
                                                                                                  HIV infected: sens 56.2%, spec 61.8%, PPV 61.9%                                                                                  

                                                                                                                                                                                                                                   

  Houwert et al. \[[@B38]\]      1998   South Africa   WHO provisional guidelines (1994)          PPV of all 3 criteria when present simultaneously: 63%                                                                           WHO diagnostic categories from 1994 used as the gold standard
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Sens: sensitivity; spec: specificity; PTB: pulmonary tuberculosis; EPTB: extrapulmonary tuberculosis; PPV: positive predictive value; NPV: negative predictive value.

###### 

Studies focusing primarily on pulmonary tuberculosis.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                         Year   Country        Scoring system               Percent also with EPTB                                                                                                                                                                                                     Validation
  ------------------------------ ------ -------------- ---------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------
  Shah et al. \[[@B12]\]         1992   India          Modified Kenneth Jones       Looked at "primary complex" (just pulmonary) versus "progressive primary complex" (pulmonary plus LAD)                                                                                                                     Not analyzed, just used in inclusion criteria

                                                                                                                                                                                                                                                                                                               

  Migliori et al. \[[@B30]\]     1992   Uganda         Migliori                     All pulmonary                                                                                                                                                                                                              Gastric aspirate: sens 96.8%, spec 92.2%, PPV 68.2%, NPV 99.4%. Response to treatment: sens 62.5%, 94.1%, PPV 57.7%, NPV 95.1%

                                                                                                                                                                                                                                                                                                               

  Beyers et al. \[[@B35]\]       1994   South Africa   Modified 1883 WHO criteria   All pulmonary---excluded extrapulmonary tuberculosis without lung involvement                                                                                                                                              Not evaluated

                                                                                                                                                                                                                                                                                                               

  Salazar et al. \[[@B32]\]      2001   Peru           Migliori                     All pts had PTB, 21/135 had EPTB as well: lymphadenopathy, intestinal-intraperitoneal TB, intra-abdominal lymphadenopathy, miliary disease, meningitis, and optic involvement. 3 with EPTB did not meet criteria for PTB   Sens 92% (Migliori) versus 80% (Peru). 3/3 Peru criteria had 73% PPV

                                                                                                                                                                                                                                                                                                               

  Sant\'Anna et al. \[[@B25]\]   2004   Brazil         Brazil Ministry of Health    82% very likely, 16% possible, 2.4% unlikely                                                                                                                                                                               All pulmonary plus 5 pts with assoc extrapulmonary TB

                                                                                                                                                                                                                                                                                                               

  Sant\'Anna et al. \[[@B24]\]   2006   Brazil         Brazil Ministry of Health    Cut off ≥40: sens 58% and spec 98% but missed 42% of confirmed PTB.\                                                                                                                                                       Pulmonary
                                                                                    Cut off ≥30: sens 89% and spec 86%                                                                                                                                                                                         

                                                                                                                                                                                                                                                                                                               

  Oberhelmen et al. \[[@B14]\]   2006   Peru           Stegen-Toledo                Not analyzed, just used in inclusion criteria                                                                                                                                                                              Pulmonary

                                                                                                                                                                                                                                                                                                               

  Marais et al. \[[@B26]\]       2006   South Africa   New                          Children ≥3 and HIV uninfected: sens 82.3%, spec 90.2%, PPV 82.3%.\                                                                                                                                                        Focused on pulmonary TB only
                                                                                    Children \<3 and HIV uninfected: sens 51.8%, spec 92.5%, PPV 90.1%. HIV infected: sens 56.2%, spec 61.8%, PPV 61.9%                                                                                                        

                                                                                                                                                                                                                                                                                                               

  Viani et al. \[[@B8]\]         2008   Mexico         Stegen-Toledo                Looked retrospectively: 10/13 highly probable, 2/13 probable, 1/13 suspicious                                                                                                                                              100% pulmonary, 54% also had disseminated

                                                                                                                                                                                                                                                                                                               

  Pedrozo et al. \[[@B23]\]      2009   Brazil         Brazil Ministry of Health    Analyzed scoring system by looking at median scores of various groups: median score of 3a and 3b sig. higher than 1 and 2, median score also was higher than the cut off of 30                                             Pulmonary only
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Sens: sensitivity; spec: specificity; PTB: pulmonary tuberculosis; EPTB: extrapulmonary tuberculosis; PPV: positive predictive value; NPV: negative predictive value.

###### 

Studies that specified how many patients were coinfected with HIV.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                       Year   Country                Total patients   Percent HIV positive   Findings
  ---------------------------- ------ ---------------------- ---------------- ---------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Madhi et al. \[[@B31]\]      1999   South Africa           130              40%                    Did not attempt to validate scoring criteria

                                                                                                     

  Kiwanuka et al. \[[@B42]\]   2001   Malawi                 110              71% (of 102 tested)    Did not attempt to validate scoring criteria

                                                                                                     

  Palme et al. \[[@B39]\]      2002   Ethiopia               517              11.2%                  Did not attempt to validate scoring criteria

                                                                                                     

  van Rheenen \[[@B18]\]       2002   Zambia                 147              30%                    Keith Edwards scoring system: sensitivity 88% and specificity 25% in this study. Most of the children with a false positive score were malnourished (48%) or had AIDS (31%)

                                                                                                     

  Marais et al. \[[@B26]\]     2006   South Africa           428              8.8%                   Sensitivity, specificity, and PPV all decreased significantly when HIV infected children included

                                                                                                     

  Edwards et al. \[[@B47]\]    2007   Democratic Republic\   91               46%                    Out of 8 scoring systems analyzed, 3/8 systems did not recommend treatment in 14% of HIV-infected children compared to 2% of noninfected children. Mean score tended to be higher for HIV-infected children, but only significant for Edwards score
                                      of Congo                                                       

                                                                                                     

  Viani et al. \[[@B8]\]       2008   Mexico                 13               100%                   Applied Stegen-Toledo criteria retrospectively but without culture results: 77% had highly probable TB, 15% probable, and 8% suspicion of TB

                                                                                                     

  Pedrozo et al. \[[@B23]\]    2009   Brazil                 239              5%                     Analyzed scoring system by looking at median scores of various groups: median score of 3a (TB+, HIV−) and 3b (TB+, HIV+) sig. higher than TB negative groups, median score of TB+ groups also was higher than the cutoff of 30
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PPV: positive predictive value.
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